Marc Studer

Marc Studer is the Senior Director, Head of ADC & mRNA Operations at Samsung Biologics and played a key leadership role in the end-to-end development of its ADC GMP services. Mr. Studer brings more than 15 years of experience in the CDMO industry, with expertise spanning Operations, MSAT, and Quality Control. Prior to joining Samsung Biologics, Mr. Studer served as Associate Director at Lonza, where he led operations as an Asset Team Lead. In this role, he was responsible for both clinical and commercial Bioconjugates manufacturing, as well as the design and ramp-up of new manufacturing assets as Operations Leader. Mr. Studer holds a master’s degree in Pharmaceutical Biotechnology from Zurich University of Applied Sciences in Switzerland.